Skip to main content

What the FDA labels say about taking them together

Guanfacine and rifampin

Guanfacine's FDA label of June 23, 2025 names rifampin in its drug interactions section; the rifampin label PlainMeds reads does not name guanfacine. The guanfacine label: “Consider dose increase”

Check it at the source: the guanfacine FDA label on DailyMed (effective June 23, 2025, Takeda Pharmaceuticals America, Inc.); the rifampin FDA label on DailyMed (effective February 11, 2026, Lupin Pharmaceuticals, Inc.).

What does the guanfacine label say about rifampin?

Guanfacine label, drug interactions

Concomitant Drug Name or Drug Class: Strong and moderate CYP3A4 inducers, e.g., rifampin, efavirenz; Clinical Rationale and Magnitude of Drug Interaction: Guanfacine is primarily metabolized by CYP3A4 and its plasma concentrations can be significantly affected resulting in a decrease in exposure; Clinical Recommendation: Consider dose increase [see ]

Source: FDA drug label (Intuniv), Takeda Pharmaceuticals America, Inc., effective June 23, 2025 (SPL set b972af81-3a37-40be-9fe1-3ddf59852528), via openFDA; the full label on DailyMed

What does the rifampin label say about guanfacine?

Rifampin's label (effective February 11, 2026) does not name guanfacine in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (rifampin), Lupin Pharmaceuticals, Inc., effective February 11, 2026 (SPL set b56004f0-f23d-47f6-80c7-39884fccbccc), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

36Guanfacine generic labelers
13Rifampin generic labelers
GuanfacineRifampin
Labeled forADHD, High blood pressuren/a
Boxed warningNoNo
Pharmacy cost (NADAC)$0.147 per tablet 1 mg tablet$0.679 per capsule 300 mg capsule
Shortage nowA presentation being discontinuedIn shortage

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?